Global Blinatumomab Market Growth 2022-2028
- LP 4850241
- 72 Pages
- February 2022
- Pharmaceuticals
The United States Blinatumomab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Blinatumomab market, reaching US$ million by the year 2028. As for the Europe Blinatumomab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Blinatumomab players cover Amgen, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Blinatumomab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Prefilled
Non-prefilled
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amgen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blinatumomab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Blinatumomab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Blinatumomab by Country/Region, 2017, 2022 & 2028
2.2 Blinatumomab Segment by Type
2.2.1 Prefilled
2.2.2 Non-prefilled
2.3 Blinatumomab Sales by Type
2.3.1 Global Blinatumomab Sales Market Share by Type (2017-2022)
2.3.2 Global Blinatumomab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Blinatumomab Sale Price by Type (2017-2022)
2.4 Blinatumomab Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Blinatumomab Sales by Application
2.5.1 Global Blinatumomab Sale Market Share by Application (2017-2022)
2.5.2 Global Blinatumomab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Blinatumomab Sale Price by Application (2017-2022)
3 Global Blinatumomab by Company
3.1 Global Blinatumomab Breakdown Data by Company
3.1.1 Global Blinatumomab Annual Sales by Company (2020-2022)
3.1.2 Global Blinatumomab Sales Market Share by Company (2020-2022)
3.2 Global Blinatumomab Annual Revenue by Company (2020-2022)
3.2.1 Global Blinatumomab Revenue by Company (2020-2022)
3.2.2 Global Blinatumomab Revenue Market Share by Company (2020-2022)
3.3 Global Blinatumomab Sale Price by Company
3.4 Key Manufacturers Blinatumomab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blinatumomab Product Location Distribution
3.4.2 Players Blinatumomab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Blinatumomab by Geographic Region
4.1 World Historic Blinatumomab Market Size by Geographic Region (2017-2022)
4.1.1 Global Blinatumomab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Blinatumomab Annual Revenue by Geographic Region
4.2 World Historic Blinatumomab Market Size by Country/Region (2017-2022)
4.2.1 Global Blinatumomab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Blinatumomab Annual Revenue by Country/Region
4.3 Americas Blinatumomab Sales Growth
4.4 APAC Blinatumomab Sales Growth
4.5 Europe Blinatumomab Sales Growth
4.6 Middle East & Africa Blinatumomab Sales Growth
5 Americas
5.1 Americas Blinatumomab Sales by Country
5.1.1 Americas Blinatumomab Sales by Country (2017-2022)
5.1.2 Americas Blinatumomab Revenue by Country (2017-2022)
5.2 Americas Blinatumomab Sales by Type
5.3 Americas Blinatumomab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blinatumomab Sales by Region
6.1.1 APAC Blinatumomab Sales by Region (2017-2022)
6.1.2 APAC Blinatumomab Revenue by Region (2017-2022)
6.2 APAC Blinatumomab Sales by Type
6.3 APAC Blinatumomab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Blinatumomab by Country
7.1.1 Europe Blinatumomab Sales by Country (2017-2022)
7.1.2 Europe Blinatumomab Revenue by Country (2017-2022)
7.2 Europe Blinatumomab Sales by Type
7.3 Europe Blinatumomab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blinatumomab by Country
8.1.1 Middle East & Africa Blinatumomab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Blinatumomab Revenue by Country (2017-2022)
8.2 Middle East & Africa Blinatumomab Sales by Type
8.3 Middle East & Africa Blinatumomab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blinatumomab
10.3 Manufacturing Process Analysis of Blinatumomab
10.4 Industry Chain Structure of Blinatumomab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blinatumomab Distributors
11.3 Blinatumomab Customer
12 World Forecast Review for Blinatumomab by Geographic Region
12.1 Global Blinatumomab Market Size Forecast by Region
12.1.1 Global Blinatumomab Forecast by Region (2023-2028)
12.1.2 Global Blinatumomab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blinatumomab Forecast by Type
12.7 Global Blinatumomab Forecast by Application
13 Key Players Analysis
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Blinatumomab Product Offered
13.1.3 Amgen Blinatumomab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
14 Research Findings and Conclusion
Table 1. Blinatumomab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Blinatumomab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Prefilled
Table 4. Major Players of Non-prefilled
Table 5. Global Blinatumomab Sales by Type (2017-2022) & (K Units)
Table 6. Global Blinatumomab Sales Market Share by Type (2017-2022)
Table 7. Global Blinatumomab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Blinatumomab Revenue Market Share by Type (2017-2022)
Table 9. Global Blinatumomab Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Blinatumomab Sales by Application (2017-2022) & (K Units)
Table 11. Global Blinatumomab Sales Market Share by Application (2017-2022)
Table 12. Global Blinatumomab Revenue by Application (2017-2022)
Table 13. Global Blinatumomab Revenue Market Share by Application (2017-2022)
Table 14. Global Blinatumomab Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Blinatumomab Sales by Company (2020-2022) & (K Units)
Table 16. Global Blinatumomab Sales Market Share by Company (2020-2022)
Table 17. Global Blinatumomab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Blinatumomab Revenue Market Share by Company (2020-2022)
Table 19. Global Blinatumomab Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Blinatumomab Producing Area Distribution and Sales Area
Table 21. Players Blinatumomab Products Offered
Table 22. Blinatumomab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Blinatumomab Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Blinatumomab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Blinatumomab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Blinatumomab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Blinatumomab Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Blinatumomab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Blinatumomab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Blinatumomab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Blinatumomab Sales by Country (2017-2022) & (K Units)
Table 34. Americas Blinatumomab Sales Market Share by Country (2017-2022)
Table 35. Americas Blinatumomab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Blinatumomab Revenue Market Share by Country (2017-2022)
Table 37. Americas Blinatumomab Sales by Type (2017-2022) & (K Units)
Table 38. Americas Blinatumomab Sales Market Share by Type (2017-2022)
Table 39. Americas Blinatumomab Sales by Application (2017-2022) & (K Units)
Table 40. Americas Blinatumomab Sales Market Share by Application (2017-2022)
Table 41. APAC Blinatumomab Sales by Region (2017-2022) & (K Units)
Table 42. APAC Blinatumomab Sales Market Share by Region (2017-2022)
Table 43. APAC Blinatumomab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Blinatumomab Revenue Market Share by Region (2017-2022)
Table 45. APAC Blinatumomab Sales by Type (2017-2022) & (K Units)
Table 46. APAC Blinatumomab Sales Market Share by Type (2017-2022)
Table 47. APAC Blinatumomab Sales by Application (2017-2022) & (K Units)
Table 48. APAC Blinatumomab Sales Market Share by Application (2017-2022)
Table 49. Europe Blinatumomab Sales by Country (2017-2022) & (K Units)
Table 50. Europe Blinatumomab Sales Market Share by Country (2017-2022)
Table 51. Europe Blinatumomab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Blinatumomab Revenue Market Share by Country (2017-2022)
Table 53. Europe Blinatumomab Sales by Type (2017-2022) & (K Units)
Table 54. Europe Blinatumomab Sales Market Share by Type (2017-2022)
Table 55. Europe Blinatumomab Sales by Application (2017-2022) & (K Units)
Table 56. Europe Blinatumomab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Blinatumomab Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Blinatumomab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Blinatumomab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Blinatumomab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Blinatumomab Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Blinatumomab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Blinatumomab Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Blinatumomab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Blinatumomab
Table 66. Key Market Challenges & Risks of Blinatumomab
Table 67. Key Industry Trends of Blinatumomab
Table 68. Blinatumomab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Blinatumomab Distributors List
Table 71. Blinatumomab Customer List
Table 72. Global Blinatumomab Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Blinatumomab Sales Market Forecast by Region
Table 74. Global Blinatumomab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Blinatumomab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Blinatumomab Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Blinatumomab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Blinatumomab Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Blinatumomab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Blinatumomab Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Blinatumomab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Blinatumomab Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Blinatumomab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Blinatumomab Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Blinatumomab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Blinatumomab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Blinatumomab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Blinatumomab Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Blinatumomab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Blinatumomab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Blinatumomab Revenue Market Share Forecast by Application (2023-2028)
Table 92. Amgen Basic Information, Blinatumomab Manufacturing Base, Sales Area and Its Competitors
Table 93. Amgen Blinatumomab Product Offered
Table 94. Amgen Blinatumomab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Amgen Main Business
Table 96. Amgen Latest Developments
List of Figures
Figure 1. Picture of Blinatumomab
Figure 2. Blinatumomab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blinatumomab Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Blinatumomab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Blinatumomab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Prefilled
Figure 10. Product Picture of Non-prefilled
Figure 11. Global Blinatumomab Sales Market Share by Type in 2021
Figure 12. Global Blinatumomab Revenue Market Share by Type (2017-2022)
Figure 13. Blinatumomab Consumed in Hospital
Figure 14. Global Blinatumomab Market: Hospital (2017-2022) & (K Units)
Figure 15. Blinatumomab Consumed in Pharmacy
Figure 16. Global Blinatumomab Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Blinatumomab Sales Market Share by Application (2017-2022)
Figure 18. Global Blinatumomab Revenue Market Share by Application in 2021
Figure 19. Blinatumomab Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Blinatumomab Revenue Market Share by Company in 2021
Figure 21. Global Blinatumomab Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Blinatumomab Revenue Market Share by Geographic Region in 2021
Figure 23. Global Blinatumomab Sales Market Share by Region (2017-2022)
Figure 24. Global Blinatumomab Revenue Market Share by Country/Region in 2021
Figure 25. Americas Blinatumomab Sales 2017-2022 (K Units)
Figure 26. Americas Blinatumomab Revenue 2017-2022 ($ Millions)
Figure 27. APAC Blinatumomab Sales 2017-2022 (K Units)
Figure 28. APAC Blinatumomab Revenue 2017-2022 ($ Millions)
Figure 29. Europe Blinatumomab Sales 2017-2022 (K Units)
Figure 30. Europe Blinatumomab Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Blinatumomab Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Blinatumomab Revenue 2017-2022 ($ Millions)
Figure 33. Americas Blinatumomab Sales Market Share by Country in 2021
Figure 34. Americas Blinatumomab Revenue Market Share by Country in 2021
Figure 35. United States Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Blinatumomab Sales Market Share by Region in 2021
Figure 40. APAC Blinatumomab Revenue Market Share by Regions in 2021
Figure 41. China Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Blinatumomab Sales Market Share by Country in 2021
Figure 48. Europe Blinatumomab Revenue Market Share by Country in 2021
Figure 49. Germany Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Blinatumomab Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Blinatumomab Revenue Market Share by Country in 2021
Figure 56. Egypt Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Blinatumomab Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Blinatumomab in 2021
Figure 62. Manufacturing Process Analysis of Blinatumomab
Figure 63. Industry Chain Structure of Blinatumomab
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
